drugset
Drugs / Hyperpolarized Bicarbonate (13C)
last change Jul 2023 re-read 3 minutes ago

Hyperpolarized Bicarbonate (13C)

Diagnostic / imaging agent

Investigated by
Bristol-Myers Squibb · U.S. Army Medical Research Acquisition Activity · University of California, San Francisco

Trials 1

today NCT05851365 · Ph 0
20242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05851365 Jul 2023 → Dec 2027 expected prostate carcinoma University of California, San Francisco Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hyperpolarized Bicarbonate (13C) ClinicalTrials.gov intervention name — accepted as the source's own label NCT05851365 ↗
Modality Diagnostic / imaging agent “hyperpolarized 13C bicarbonate imaging” NCT05851365 ↗
Route Intravenous “Given IV” NCT05851365 ↗